Cencora, Inc. (NYSE: COR)
Health Care · Health Care Providers & Services · US
$328.06
+1.33% today · +13.8% 1Y
Cencora, Inc. (NYSE: COR) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $62.60B and employs 49,000 people.
Over the last twelve months the share price has gained 13.8%, trading between 244.82 and 377.54.
Tweenvest scores Cencora, Inc. across four factors: quality 79/100, value 31/100, growth 57/100, dividend 66/100. Its strongest factor is quality.
COR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $62.60B
- Revenue (TTM)
- $332.77B
- P/E
- 24.37
- EPS
- 13.46
- Dividend yield
- 0.74%
- Beta (5Y)
- 0.57
- 52-week high
- $377.54
- 52-week low
- $244.82
- Avg volume (3M)
- —
- Shares outstanding
- 190.83M
- Employees
- 49,000
- Next earnings
- —
About Cencora, Inc.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
- ISIN
- US03073E1055
- Founded
- 1871
- Listed since
- Apr 4, 1995
- Exchange
- New York Stock Exchange
- Currency
- USD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $355.98B | $396.59 | -0.54% |
| CVS Health CorporationNYSE: CVS | $118.82B | $92.90 | -1.29% |
| McKesson CorporationNYSE: MCK | $105.52B | $905.09 | +3.58% |
| HCA Healthcare, Inc.NYSE: HCA | $92.83B | $428.76 | -0.11% |
| Elevance Health, Inc.NYSE: ELV | $86.50B | $398.87 | -0.93% |
| The Cigna GroupNYSE: CI | $73.81B | $279.32 | -0.40% |
| Cardinal Health, Inc.NYSE: CAH | $55.33B | $237.92 | +2.39% |
| Humana Inc.NYSE: HUM | $46.80B | $389.71 | +0.80% |
Figures last refreshed Aug 18, 2026.